Comparable safety and non-inferior immunogenicity of the SARS-CoV-2 mRNA vaccine candidate PTX-COVID19-B and BNT162b2 in a phase 2 randomized, observer-blinded study
Article in Scientific Reports (March 2024)
The most recent citing publications are shown below. View all 353 publications that cite this research output on Dimensions.
Article in Scientific Reports (March 2024)
Article in Biomedicines (March 2024)
Article in Cell Reports (February 2024)